Paige’s Razik Yousfi: Biden has set expectations for AI, but details will come via federal guidelines

The challenge of making the move from conversational AI to autonomous scientific discovery
Advancing from level II to level III AI agents in precision medicine

Artificial intelligence is rapidly transforming biomedical research and healthcare. Large language models, foundation models, and AI agents are increasingly being deployed to assist with data interpretation, literature review, clinical decision support, and translational research.

July 10, 2026

Vol.52 No.27

By Enrique Velazquez-Villarreal

Cancer Policy

FDA halts public release of Complete Response Letters, following citizen petition

FDA will temporarily stop publicly releasing rejection letters as it evaluates potential response to a citizen petition issued by an unnamed pharmaceutical company challenging the legality of the practice.

July 10, 2026

Vol.52 No.27

By Claire Marie Porter

Cancer Policy

FDA proposes rule to hold foreign tobacco companies to U.S. standards

FDA has issued a proposed rule to require both foreign and domestic tobacco manufacturers to register their facilities and list their products with the agency. This closes a regulatory gap, holding overseas e-cigarette and tobacco makers to the same standards as U.S. companies.

July 10, 2026

Vol.52 No.27

By Claire Marie Porter

Clinical Trials & Tribulations

Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives

I performed my first colonoscopy as a board-certified gastroenterologist more than 20 years ago, at a time when the procedure was firmly established as the “gold standard” for colorectal cancer screening.

July 02, 2026

Vol.52 No.26

By Paul J. Limburg

Clinical Trials & Tribulations

More than 50 million Americans remain unscreened for colon cancer
New guidelines offer another option

For decades, we have faced a central challenge in colorectal cancer screening. One in three eligible Americans—over 50 million people—remain unscreened despite established methods like colonoscopy or stool-based tests existing for decades. This gap persists even though early detection saves lives, and even as colorectal cancer is now the number one cancer killer for Americans under 50.

FDA allows ZYN nicotine pouches to make marketing claim: ZYN is safer than cigarettes

FDA is allowing ZYN nicotine pouches, a tobaccoless product that has soared in popularity since in recent years, to make the claim that its products are safer than cigarettes.

July 02, 2026

Vol.52 No.26

By Sara Willa Ernst

Paige’s Razik Yousfi: Biden has set expectations for AI, but details will come via federal guidelines

YOU MAY BE INTERESTED IN

The challenge of making the move from conversational AI to autonomous scientific discovery
Advancing from level II to level III AI agents in precision medicine

FDA halts public release of Complete Response Letters, following citizen petition

FDA proposes rule to hold foreign tobacco companies to U.S. standards

Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives

More than 50 million Americans remain unscreened for colon cancer
New guidelines offer another option

FDA allows ZYN nicotine pouches to make marketing claim: ZYN is safer than cigarettes

Renew today!

Subscriber content

Never miss an issue!

Login

Paige’s Razik Yousfi: Biden has set expectations for AI, but details will come via federal guidelines

YOU MAY BE INTERESTED IN

The challenge of making the move from conversational AI to autonomous scientific discoveryAdvancing from level II to level III AI agents in precision medicine

FDA halts public release of Complete Response Letters, following citizen petition

FDA proposes rule to hold foreign tobacco companies to U.S. standards

Is it time to re-assess the practice and practicality of screening colonoscopy?Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives

More than 50 million Americans remain unscreened for colon cancerNew guidelines offer another option

FDA allows ZYN nicotine pouches to make marketing claim: ZYN is safer than cigarettes

Never miss an issue!

Login

The challenge of making the move from conversational AI to autonomous scientific discovery
Advancing from level II to level III AI agents in precision medicine

Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives

More than 50 million Americans remain unscreened for colon cancer
New guidelines offer another option